Skip to content
  • Русский
  • Українська
smart-pharma.group
smart-pharma.group
pharmaceutical consulting services
  • Home
  • Services
  • About Us
  • Pharmacovigilance
    • Report AE
  • Blog
  • Contact Us

Blog

Blog

  • Another Company recalls its products due to the presence of Nitrosamine impurities

    06/07/2020
    Another Company recalls its products due to the presence of Nitrosamine impurities

    Nitrosamine impurities, including N-Nitrosodimethylamine (NDMA), and N-Nitrosodiethylamine (NDEA), are probable human carcinogens, and N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) is a potential human…


  • Local Person responsible for Pharmacovigilance in Azerbaijan Republic

    19/06/2020
    Local Person responsible for Pharmacovigilance in Azerbaijan Republic

    Are you aware that Decree of the Cabinet of Ministers of Azerbaijan RepublicNo. 503 on the Rules of Pharmacovigilance of…


  • PIC/S adopts cross contamination

    10/06/2020
    PIC/S adopts                         cross contamination

    Two new Pharmaceutical Inspection Co-Operation Scheme (PIC/S) guidance documents entered into force on 1 June 2020, a questions and answers…


  • Global regulators commit to cooperate on observational research in the context of COVID-19

    22/05/2020
    Global regulators commit to cooperate on observational research in the context of COVID-19

    On 19 May 2020 at a second workshop on observational studies co-organised by the EMA and Health Canada within the…


  • 50 days to the start of the drug movement monitoring (DMM) system in the Russian Federation

    13/05/2020
    50 days to the start of the drug movement monitoring (DMM) system in the Russian Federation

    50 days left to the official start of the all-Russian labelling according to the new requirements of the Decree of…


  • National Center for Expertise of Medicines and Medical Devices of the Ministry of Health of the Republic of Kazakhstan approved new standard contract templates

    30/04/2020
    National Center for Expertise of Medicines and Medical Devices of the Ministry of Health of the Republic of Kazakhstan approved new standard contract templates

    National Center for Expertise of Medicines and Medical Devices of the Committee for Quality Control and Safety of Goods and…


  • Five new guidances posted by the European Commission’s Medical Device Coordination Group

    30/04/2020
    Five new guidances posted by the European Commission’s Medical Device Coordination Group

    The European Commission’s Medical Device Coordination Group posted five new guidances on demonstrating equivalence to existing devices; clinical evidence for…


  • Amended Rules No. 736 “On the Rules of Evaluation of Medicines and Medical Devices” become effective on April 9, 2020 in Republic of Kazakhstan

    13/04/2020
    Amended Rules No. 736   “On the Rules of Evaluation of Medicines and Medical Devices” become effective  on April 9, 2020 in Republic of Kazakhstan

    Amended Rules No. 736 “On the Rules of Evaluation of Medicines and Medical Devices” become effective on April 9, 2020.…


  • Happy Easter holidays!

    13/04/2020
    Happy Easter holidays!

    SmartPharma Group wishes this Easter would inspire you to new hope, happiness, prosperity and abundance!


  • Suspension of work of the Department of Medicines Supply in Kyrgyz Republic due to COVID-19 pandemic

    02/04/2020
    Suspension of work of the  Department of Medicines Supply in Kyrgyz Republic due to COVID-19 pandemic

    The Department of Drug Supply of the Kyrgyz Republic suspends its work from 02.04.2020. Due to the spread of the…


Previous Page
1 2 3 4 … 6
Next Page

Recent Posts

  • The Russian side opposed to postpone Implementation period of the EAEU Rules of marketing authorisation 03/12/2020
  • MedSafety app launch in the Kyrgyz Republic 25/11/2020
  • Important amendments to the EAEU legislative acts 20/10/2020

Recent Comments

    Archives

    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019

    Contact Us

    info@smart-pharma.group

    Head office EU:
    23 Upes St., Vilnus,
    LT-08128, Lithuania

    +37 052 060 0 94


    CIS office:
    26 Peremohy Ave,
    Kyiv, 04116, Ukraine

    +38 044 390 31 90

    Follow Us

    EAEU office:
    7 Aprelia St., 2/10, 48,
    Bishkek, 72007, Kyrgystan

    +99 655 007 7073

    • About Us
    • Services
    • Pharmacovigilance
    Copyright © 2022 smart-pharma.group